Works matching IS 03057453 AND DT 2020 AND VI 75 AND IP 11


Results: 48
    1
    2
    3
    4
    5
    6
    7
    8

    Prevalence of resistance-associated substitutions and retreatment of patients failing a glecaprevir/pibrentasvir regimen.

    Published in:
    2020
    By:
    • de Salazar, Adolfo;
    • Dietz, Julia;
    • di Maio, Velia Chiara;
    • Vermehren, Johannes;
    • Paolucci, Stefania;
    • Müllhaupt, Beat;
    • Coppola, Nicola;
    • Cabezas, Joaquín;
    • Stauber, Rudolf E;
    • Puoti, Massimo;
    • Arenas Ruiz Tapiador, Juan Ignacio;
    • Graf, Christiana;
    • Aragri, Marianna;
    • Jimenez, Miguel;
    • Callegaro, Annapaola;
    • Pascasio Acevedo, Juan Manuel;
    • Macias Rodriguez, Manuel Alberto;
    • Rosales Zabal, Jose Miguel;
    • Micheli, Valeria;
    • Garcia Del Toro, Miguel
    Publication type:
    journal article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35

    The impact of sofosbuvir/daclatasvir or ribavirin in patients with severe COVID-19.

    Published in:
    2020
    By:
    • Eslami, Gholamali;
    • Mousaviasl, Sajedeh;
    • Radmanesh, Esmat;
    • Jelvay, Saeed;
    • Bitaraf, Saeid;
    • Simmons, Bryony;
    • Wentzel, Hannah;
    • Hill, Andrew;
    • Sadeghi, Anahita;
    • Freeman, James;
    • Salmanzadeh, Shokrollah;
    • Esmaeilian, Hani;
    • Mobarak, Morteza;
    • Tabibi, Ramin;
    • Jafari Kashi, Amir Hosein;
    • Lotfi, Zahra;
    • Talebzadeh, Seyed Mehdi;
    • Wickramatillake, Aseni;
    • Momtazan, Mahboobeh;
    • Hajizadeh Farsani, Majid
    Publication type:
    journal article
    36

    Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial.

    Published in:
    2020
    By:
    • Sadeghi, Anahita;
    • Ali Asgari, Ali;
    • Norouzi, Alireza;
    • Kheiri, Zahedin;
    • Anushirvani, Amir;
    • Montazeri, Mahnaz;
    • Hosamirudsai, Hadiseh;
    • Afhami, Shirin;
    • Akbarpour, Elham;
    • Aliannejad, Rasoul;
    • Radmard, Amir Reza;
    • Davarpanah, Amir H;
    • Levi, Jacob;
    • Wentzel, Hannah;
    • Qavi, Ambar;
    • Garratt, Anna;
    • Simmons, Bryony;
    • Hill, Andrew;
    • Merat, Shahin
    Publication type:
    journal article
    37

    Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a single-centre, randomized controlled trial.

    Published in:
    2020
    By:
    • Abbaspour Kasgari, Hamideh;
    • Moradi, Siavash;
    • Shabani, Amir Mohammad;
    • Babamahmoodi, Farhang;
    • Davoudi Badabi, Ali Reza;
    • Davoudi, Lotfollah;
    • Alikhani, Ahmad;
    • Hedayatizadeh Omran, Akbar;
    • Saeedi, Majid;
    • Merat, Shahin;
    • Wentzel, Hannah;
    • Garratt, Anna;
    • Levi, Jacob;
    • Simmons, Bryony;
    • Hill, Andrew;
    • Tirgar Fakheri, Hafez
    Publication type:
    journal article
    38
    39
    40
    41
    42
    43
    44
    45
    46

    Molecular and biochemical insights into the in vivo evolution of AmpC-mediated resistance to ceftolozane/tazobactam during treatment of an MDR Pseudomonas aeruginosa infection.

    Published in:
    2020
    By:
    • Arca-Suárez, Jorge;
    • Vázquez-Ucha, Juan Carlos;
    • Fraile-Ribot, Pablo Arturo;
    • Lence, Emilio;
    • Cabot, Gabriel;
    • Martínez-Guitián, Marta;
    • Lasarte-Monterrubio, Cristina;
    • Rodríguez-Iglesias, Manuel;
    • Beceiro, Alejandro;
    • González-Bello, Concepción;
    • Galán-Sánchez, Fátima;
    • Oliver, Antonio;
    • Bou, Germán
    Publication type:
    journal article
    48